Personal information

Emails & domains

Verified email addresses

Verified email domains

Other IDs

SciProfiles: 1871661

Activities

Collapse all

Employment (5)

Max Planck Institute of Psychiatry: Munich, Bavaria, DE

2023-04 to present | postdoc (Emotion Research Department)
Employment
Source: Self-asserted source
Tibor Stark

Masaryk University: Brno, CZ

2021-12 to 2023-06 | Researcher (Dept of Pharmacology, Faculty of Medicine)
Employment
Source: Self-asserted source
Tibor Stark

Max Planck Institute of Psychiatry: Munich, Bavaria, DE

2021-03-01 to 2023-03-31 | postdoc (Neuroimaging Core Unit)
Employment
Source: Self-asserted source
Tibor Stark

Masaryk University: Brno, CZ

2015 to 2021-12 | PhD. student (Department of Pharmacology)
Employment
Source: Self-asserted source
Tibor Stark

Max-Planck-Institut für Psychiatrie: Munchen, Bayern, DE

2018 to 2021-02 | Technical Assistant/PhD student (Neuronal Plasticity Group)
Employment
Source: Self-asserted source
Tibor Stark

Education and qualifications (2)

Veterinarni a Farmaceuticka Univerzita v Brne: Brno, CZ

Master of Pharmacy
Education
Source: Self-asserted source
Tibor Stark

Masaryk University: Brno, CZ

2021-12 | Ph.D. (Department of Pharmacology)
Education
Source: Self-asserted source
Tibor Stark

Works (19)

FKBP51 in glutamatergic forebrain neurons promotes early life stress inoculation in female mice

Nature Communications
2025-03-14 | Journal article
DOI: 10.1038/s41467-025-57952-x
Contributors: Lotte van Doeselaar; Alexandra Abromeit; Tibor Stark; Danusa Menegaz; Markus Ballmann; Shiladitya Mitra; Huanqing Yang; Ghalia Rehawi; Rosa-Eva Huettl; Joeri Bordes et al.
Source: check_circle
Crossref

Neuropeptide CRH prevents premature differentiation of OPCs following CNS injury and in early postnatal development

2025-02-16 | Preprint
DOI: 10.1101/2025.02.14.638041
Contributors: Clemens Ries; Tibor Stark; Benoit Boulat; Torben Ruhwedel; Jan Philipp Delling; Antonio Miralles Infante; Julia T. von Poblotzki; Alessandro Ulivi; Iven-Alex von Mücke-Heim; Simon Chang et al.
Source: check_circle
Crossref

Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats

Pharmacological Reports
2024-05-24 | Journal article
DOI: 10.1007/s43440-024-00604-6
Part of ISSN: 1734-1140
Part of ISSN: 2299-5684
Contributors: Francesca Frescura; Tibor Stark; Maria Cristina Tomasini; Serena Di Martino; Jana Ruda-Kucerova; Filippo Drago; Luca Ferraro; Vincenzo MICALE; sarah beggiato; Tibor Stark
Source: Self-asserted source
Tibor Stark

Sex-specific and opposed effects of FKBP51 in glutamatergic and GABAergic neurons: Implications for stress susceptibility and resilience

Proceedings of the National Academy of Sciences
2023-06-06 | Journal article
DOI: 10.1073/pnas.2300722120
Contributors: Lotte van Doeselaar; Tibor Stark; Shiladitya Mitra; Huanqing Yang; Joeri Bordes; Linda Stolwijk; Clara Engelhardt; Veronika Kovarova; Sowmya Narayan; Lea M. Brix et al.
Source: check_circle
Crossref

The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology

International Journal of Molecular Sciences
2023-02-15 | Journal article
DOI: 10.3390/ijms24043907
Contributors: Martina Di Bartolomeo; Tibor Stark; Serena Di Martino; Fabio Arturo Iannotti; Jana Ruda-Kucerova; Giovanni Luca Romano; Martin Kuchar; Samuele Laudani; Petr Palivec; Fabiana Piscitelli et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets.

Pharmacology & therapeutics
2022-09-11 | Journal article
DOI: 10.1016/j.pharmthera.2022.108279
PMID: 36103902
Contributors: Micale V; Di Bartolomeo M; Di Martino S; Stark T; Dell'Osso B; Drago F; D'Addario C
Source: Self-asserted source
Tibor Stark

Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia

Biomolecules
2022-01-10 | Journal article
DOI: 10.3390/biom12010108
Part of ISSN: 2218-273X
Contributors: Tibor Stark; Fabio Arturo Iannotti; Serena Di Martino; Martina Di Bartolomeo; Jana Ruda-Kucerova; Fabiana Piscitelli; Carsten T. Wotjak; Claudio D’Addario; Filippo Drago; Vincenzo Di Marzo et al.
Source: Self-asserted source
Tibor Stark

Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment

Pharmacological Research
2021-12 | Journal article
DOI: 10.1016/j.phrs.2021.105938
Part of ISSN: 1043-6618
Contributors: Tibor Stark; Serena Di Martino; Filippo Drago; Carsten T. Wotjak; Vincenzo Micale
Source: Self-asserted source
Tibor Stark

Structural correlates of trauma-induced hyperarousal in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry
2021-12 | Journal article
DOI: 10.1016/j.pnpbp.2021.110404
Part of ISSN: 0278-5846
Contributors: Julia Ruat; Daniel E. Heinz; Florian P. Binder; Tibor Stark; Robert Neuner; Alice Hartmann; Paul M. Kaplick; Alon Chen; Michael Czisch; Carsten T. Wotjak
Source: Self-asserted source
Tibor Stark

Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats

Pharmacological Research
2021-02 | Journal article
DOI: 10.1016/j.phrs.2020.105357
Part of ISSN: 1043-6618
Contributors: Martina Di Bartolomeo; Tibor Stark; Oriana Maria Maurel; Fabio Arturo Iannotti; Martin Kuchar; Jana Ruda-Kucerova; Fabiana Piscitelli; Samuele Laudani; Vladimir Pekarik; Salvatore Salomone et al.
Source: Self-asserted source
Tibor Stark

Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation

Toxicology and Applied Pharmacology
2020-11 | Journal article
DOI: 10.1016/j.taap.2020.115214
Part of ISSN: 0041-008X
Contributors: Katerina Horska; Hana Kotolova; Michal Karpisek; Zuzana Babinska; Tomas Hammer; Jiri Prochazka; Tibor Stark; Vincenzo Micale; Jana Ruda-Kucerova
Source: Self-asserted source
Tibor Stark

Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment

Biochemical Pharmacology
2020-07 | Journal article
DOI: 10.1016/j.bcp.2020.114004
Contributors: Tibor Stark; Martina Di Bartolomeo; Roberta Di Marco; Eva Drazanova; Chiara Bianca Maria Platania; Fabio Arturo Iannotti; Jana Ruda-Kucerova; Claudio D'Addario; Lucie Kratka; Vladimir Pekarik et al.
Source: check_circle
Crossref

Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats

Scientific Reports
2019-04-15 | Journal article
DOI: 10.1038/s41598-019-42532-z
Contributors: Eva Drazanova; Jana Ruda-Kucerova; Lucie Kratka; Tibor Stark; Martin Kuchar; Michal Maryska; Filippo Drago; Zenon Starcuk, Jr.; Vincenzo Micale
Source: check_circle
Crossref

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

Neuropharmacology
2019-03 | Journal article
DOI: 10.1016/j.neuropharm.2018.11.035
Part of ISSN: 0028-3908
Source: Self-asserted source
Tibor Stark

HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals.

Journal of cellular physiology
2017-05 | Journal article
DOI: 10.1002/jcp.25914
PMID: 28300292
Contributors: Večeřa J; Bártová E; Krejčí J; Legartová S; Komůrková D; Rudá-Kučerová J; Štark T; Dražanová E; Kašpárek T; Šulcová A et al.
Source: Self-asserted source
Tibor Stark via Europe PubMed Central

Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.

Neurotoxicity research
2017-04 | Journal article
DOI: 10.1007/s12640-017-9718-9
PMID: 28421529
Contributors: Ruda-Kucerova J; Babinska Z; Stark T; Micale V
Source: Self-asserted source
Tibor Stark via Europe PubMed Central

A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.

Schizophrenia research
2017-01 | Journal article
DOI: 10.1016/j.schres.2017.01.022
PMID: 28108228
Contributors: D'Addario C; Micale V; Di Bartolomeo M; Stark T; Pucci M; Sulcova A; Palazzo M; Babinska Z; Cremaschi L; Drago F et al.
Source: Self-asserted source
Tibor Stark via Europe PubMed Central

Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?

Pharmacological research
2016-11 | Journal article
DOI: 10.1016/j.phrs.2016.11.021
PMID: 27884725
Contributors: Androvicova R; Horacek J; Stark T; Drago F; Micale V
Source: Self-asserted source
Tibor Stark via Europe PubMed Central

Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
2016-06 | Journal article
DOI: 10.1080/15622975.2016.1190032
PMID: 27223864
Contributors: Ruda-Kucerova J; Babinska Z; Amchova P; Stark T; Drago F; Sulcova A; Micale V
Source: Self-asserted source
Tibor Stark via Europe PubMed Central
How many people are using ORCID?